{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Noonan syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_megalostim",
          "name": "Megalostim"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_thrombopoietin",
          "name": "Thrombopoietin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_epoetin_alfa",
          "name": "Epoetin alfa"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_interferon_alpha",
          "name": "Interferon alpha"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_mesna",
          "name": "Mesna"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_asparaginase",
          "name": "Asparaginase"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vemurafenib",
          "name": "Vemurafenib"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_hydroxyurea",
          "name": "Hydroxyurea"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_bortezomib",
          "name": "Bortezomib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_nelarabine",
          "name": "Nelarabine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_simvastatin",
          "name": "Simvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_megalostim",
          "type": "Drug",
          "label": "Megalostim",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin",
          "type": "Drug",
          "label": "Thrombopoietin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_epoetin_alfa",
          "type": "Drug",
          "label": "Epoetin alfa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interferon_alpha",
          "type": "Drug",
          "label": "Interferon alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mesna",
          "type": "Drug",
          "label": "Mesna",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_asparaginase",
          "type": "Drug",
          "label": "Asparaginase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vemurafenib",
          "type": "Drug",
          "label": "Vemurafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_hydroxyurea",
          "type": "Drug",
          "label": "Hydroxyurea",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nelarabine",
          "type": "Drug",
          "label": "Nelarabine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_simvastatin",
          "type": "Drug",
          "label": "Simvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_pdgfra",
          "type": "Target",
          "label": "PDGF Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_jak2",
          "type": "Target",
          "label": "JAK2",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_cell_growth",
          "type": "Pathway",
          "label": "Cell Growth Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_erythropoiesis",
          "type": "Pathway",
          "label": "Erythropoiesis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_immune_response",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_noonan_syndrome",
          "type": "Disease",
          "label": "Noonan Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_megalostim",
          "target": "target_pdgfra",
          "relation": "activates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与血小板生成相关，可能影响 Noonan 综合症"
        },
        {
          "source": "drug_thrombopoietin",
          "target": "target_pdgfra",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于血小板生成，关联 Noonan"
        },
        {
          "source": "drug_epoetin_alfa",
          "target": "target_jak2",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "促进红细胞生成，相关 Noonan 综合症"
        },
        {
          "source": "drug_interferon_alpha",
          "target": "pathway_immune_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "调节免疫反应，可能与 Noonan 相关"
        },
        {
          "source": "drug_mesna",
          "target": "pathway_cell_growth",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响细胞生长，间接与 Noonan 相关"
        },
        {
          "source": "drug_asparaginase",
          "target": "pathway_cell_growth",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "对细胞周期有影响，可能间接相关"
        },
        {
          "source": "drug_sirolimus",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "抑制细胞生长，可能影响 Noonan"
        },
        {
          "source": "drug_vemurafenib",
          "target": "target_jak2",
          "relation": "inhibits",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与细胞信号传导相关"
        },
        {
          "source": "drug_hydroxyurea",
          "target": "pathway_erythropoiesis",
          "relation": "activates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "增长红细胞数目，关联 Noonan"
        },
        {
          "source": "drug_bortezomib",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "有潜在抑制作用"
        },
        {
          "source": "drug_nelarabine",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "影响细胞周期，可能关联"
        },
        {
          "source": "drug_simvastatin",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "调节生长信号，可能与 Noonan 相关"
        },
        {
          "source": "target_pdgfra",
          "target": "pathway_cell_growth",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "参与细胞增殖与生长"
        },
        {
          "source": "target_jak2",
          "target": "pathway_erythropoiesis",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与红细胞生成相关"
        },
        {
          "source": "pathway_cell_growth",
          "target": "disease_noonan_syndrome",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "细胞生长失调可能导致 Noonan"
        },
        {
          "source": "pathway_erythropoiesis",
          "target": "disease_noonan_syndrome",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有关红细胞生成异常"
        },
        {
          "source": "pathway_immune_response",
          "target": "disease_noonan_syndrome",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "免疫反应失调可能与 Noonan 相关"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物可能通过影响特定靶标和通路来治疗 Noonan 综合症",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "药物间的机制不仅多样化，还包括细胞生长及红细胞生成的调节",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物有足够的生物利用度以影响靶器官"
    ],
    "uncertainties": [
      "药物在 Noonan 综合症中真正的疗效尚需更进一步的研究"
    ],
    "next_focus_for_pi": [
      "是否需要进一步确认靶点/通路关联的实验数据？"
    ]
  }
}